While we have likely not even hit the peak of the coronavirus crisis yet, whenever the epidemic does come under control, many expect companies and markets impacted by the deadly virus to bounce back. However, as one fund manager cited in today’s article notes, “Everyone thinks everything is going to bounce if demand comes back, but previous incidents have shown that not every company will benefit the same way”. For three sectors – and specific companies within those sectors – that could face particularly difficult roads to recovery, CLICK HERE.
“The coronavirus has spread seemingly indiscriminately, but its impact on stocks has been more focused,” notes the author of today’s article, who proceeds to identify some potential bargains among some of the stocks that have been pummeled by the virus: airlines, cruise-ship and casino operators, oil companies and more. For more, CLICK HERE.
As the number of cases of infection by the novel coronavirus around the world rises, so are shares of a number of biotech companies with exposure to experimental vaccines (as was the case a few years back during the Ebola crisis). For four such biotech stocks – two of which are up over 250% since the beginning of the year – CLICK HERE.
In response to the spread of the new Chinese coronavirus – including its reaching the U.S. – U.S. stocks initially tumbled before rebounding as investors focused on positive earnings news. With more bad news and fear concerning the virus likely on the way, what will the virus’s impact be on the stock market? Today’s article provides a comprehensive look at the virus’s impact on Chinese stocks, China-exposed retailers, travel and gaming stocks, and biotech stocks – as well as what history suggests is coming next, potential buying opportunities from coronavirus-triggered selloffs and more. CLICK HERE.